SDS denaturation of complement factor C3 as a model for allosteric modifications occurring during C3b binding: demonstration of a profound conformational change by means of circular dichroism and quantitative immunoprecipitation.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Immunology Letters

• Publication date

  1986-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0165-2478(86)90118-5PMID 2428739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H. Spectroscopic and enzymological studies.

  1983cited by this paper
• Non-enzymic activation of the covalent binding reaction of the complement protein C3.

  1983cited by this paper
• Analogous antigenic alterations elicited in C3 by physiologic binding and by denaturation in the presence of sodium dodecylsulfate.

  1982cited by this paper
• Large scale isolation of functionally active components of the human complement system.

  1981cited by this paper
• The structure and function of the third component of human complement--I. The nature and extent of conformational changes accompanying C3 activation.

  1981cited by this paper
• Altered antigenic expressions of human C3 and C5, their subunits and fragments following exposure to denaturing conditions.

  1980cited by this paper
• Third component of human complement: structural analysis of the polypeptide chains of C3 and C3b.

  1979cited by this paper
• Third component of human complement: purification from plasma and physicochemical characterization.

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Human C3 and C5: subunit structure and modifications by trypsin and C42-C423.

  1975cited by this paper
• Changes in antigenic properties of human C3 upon activation and conversion by trypsin.

  1974cited by this paper
• Maturation of the head of bacteriophage T4. I. DNA packaging events.

  1973cited by this paper
• Computed circular dichroism spectra for the evaluation of protein conformation.

  1969cited by this paper
• Antigenic determinants of human beta-1c and beta-1g-globulins.

  1966cited by this paper
• Antigenic Determinants of Human β1C- and β1G-Globulins

  1966cited by this paper

• Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18

  2015cites this paper
• To drive or be driven: the path of a mouse model of recurrent pregnancy loss.

  2014cites this paper
• Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus

  2012cites this paper
• The tick-over theory revisited: is C3 a contact-activated protein?

  2012cites this paper
• Complement Inactivation by Recombinant Human C3 Derivatives

  2004cites this paper
• Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1253 Complement Activation Triggered by Biomaterial Surfaces Mechanisms and Regulation

  2003cites this paper
• an Initiating Alternative Pathway Convertase C3 Adsorbed to a Polymer Surface Can Form

  2002cites this paper
• On the binding of complement to solid artificial surfaces in vitro.

  2002cites this paper
• C3 Adsorbed to a Polymer Surface Can Form an Initiating Alternative Pathway Convertase1

  2002cites this paper
• Components and Reactivity

  1998cites this paper
• Immunohistochemical localization of the oestrogen-responsive 110 kDa and 74 kDa polypeptides and complement component C3 in the rat genital tract after oestrogen treatment and during the oestrous cycle.

  1993cites this paper
• Molecular aspects of C3 interactions and structural/functional analysis of C3 from different species.

  1990cites this paper
• Kinetics of the classical complement activation cascade.

  1990cites this paper
• Structural and functional analysis of C3 using monoclonal antibodies.

  1990cites this paper
• The Third Component of Complement

  1990cites this paper
• Distinctive expression of neoantigenic C3(D) epitopes on bound C3 following activation and binding to different target surfaces in normal and pathological human sera.

  1989cites this paper
• Molecular organization and function of the complement system.

  1988cites this paper
• Use of antisera to the isolated alpha and beta subunits of C3 as probes to study functional sites present on particle-bound C3b but absent on native soluble forms of C3.

  1988cites this paper
• Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragments.

  1987cites this paper
• Quantitation and antigenic characterization of bound C3 of circulating immune complexes in systemic lupus erythematosus, rheumatoid arthritis, and primary biliary cirrhosis

  1987cites this paper
• Human C3 Derivatives Complement Inactivation by Recombinant

  year unknowncites this paper